Drug development: The bioisosteric concept;Arzneistoffentwicklung: Das bioisosterie-konzept

Chemie in Unserer Zeit

Volumn 38, Issue 5, 2004, Pages 320-324

  Siebert, Carsten D ^a,b,c,d  

^a GOETHE UNIVERSITY   (Germany)

^b Beilstein Chemiedaten/Software GmbH   (Germany)

^c ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; AROMATIC COMPOUND; BENZENE DERIVATIVE; BENZODIAZEPINE; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; FURAN DERIVATIVE; NEUROLEPTIC AGENT; PROSTAGLANDIN SYNTHASE; PYRIDINE DERIVATIVE; THIOPHENE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATOM; CYCLIZATION; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG RESEARCH; DRUG STRUCTURE; PROCESS DEVELOPMENT; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TREATMENT INDICATION;

EID: 8844276775     PISSN: 00092851     EISSN: None     Source Type: Journal    
DOI: 10.1002/ciuz.200400331     Document Type: Article

References (3)

1. E. Mutschier, Arzneimittelwirkungen, 8. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart, 2001.
2. H.-J. Böhm, G. Klebe und H. Kubinyi, Wirkstoffdesign, Spektrum Akademischer Verlag, 1996.
3. Druckwerk Pharmazeutische Stoffliste und ABDA-Datenbank, ABDATA Pharma-Daten-Service, 2004.